|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$2.37 |
$2.42 |
$2.27 |
$2.38 |
249.60K | 03/25/2024 |
$2.46 |
$2.49 |
$2.36 |
$2.39 |
154.80K | 03/26/2024 |
$2.37 |
$2.49 |
$2.35 |
$2.40 |
47.40K | 03/27/2024 |
$2.40 |
$2.44 |
$2.36 |
$2.38 |
43.40K | 03/28/2024 |
$2.41 |
$2.47 |
$2.23 |
$2.29 |
108.70K |
|
ProQR Therapeutics is a clinical stage biopharmaceutical company. Co. is developing a pipeline of RNA therapies for inherited retinal diseases. Beyond its clinical portfolio, Co. has discovered and developed two proprietary RNA editing platform technologies, Axiomer and TRIDENT. Co.'s editing oligonucleotides are designed to recruit endogenous Adenosine Deaminases Acting on RNA, enzymes to make single nucleotide changes in the RNA in a manner at a desired location. TRIDENT is Co.'s RNA pseudouridylation platform that enables the selective suppression of nonsense mutations that cause human genetic disease. | |
|
ProQR Therapeutics N.V. (PRQR) has the following price history information. Looking back at PRQR historical stock prices for the last five trading days, on March 22, 2024, PRQR opened at $2.37, traded as high as $2.42 and as low as $2.27, and closed at $2.38. Trading volume was a total of 249.60K shares. On March 25, 2024, PRQR opened at $2.46, traded as high as $2.49 and as low as $2.36, and closed at $2.39. Trading volume was a total of 154.80K shares. On March 26, 2024, PRQR opened at $2.37, traded as high as $2.49 and as low as $2.35, and closed at $2.40. Trading volume was a total of 47.40K shares. On March 27, 2024, PRQR opened at $2.40, traded as high as $2.44 and as low as $2.36, and closed at $2.38. Trading volume was a total of 43.40K shares. On March 28, 2024, PRQR opened at $2.41, traded as high as $2.47 and as low as $2.23, and closed at $2.29. Trading volume was a total of 108.70K shares.
PRQR Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ProQR Therapeutics N.V. shares, starting with a $10,000 purchase of PRQR, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/18/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$14.73 |
|
End price/share: |
$2.29 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-84.45% |
|
Average Annual Total Return: |
-17.74% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,554.61 |
|
Years: |
9.53 |
|
|
|
Date |
Close |
03/22/2024 | $2.38 | 03/25/2024 | $2.39 | 03/26/2024 | $2.40 | 03/27/2024 | $2.38 | 03/28/2024 | $2.29 |
|
|